Generated by GPT-5-mini| Innosuisse | |
|---|---|
| Name | Innosuisse |
| Type | Swiss federal agency |
| Founded | 2018 |
| Headquarters | Bern, Switzerland |
| Key people | Swiss Federal Department of Economic Affairs, Education and Research |
Innosuisse Innosuisse is the Swiss agency for promoting innovation and supporting technology transfer between research institutions and industry in Switzerland. It provides competitive funding, networking, and coaching to startups, small and medium-sized enterprises, and collaborative consortia, operating in the context of Swiss federal policy instruments and research frameworks. The agency aims to accelerate commercialization of scientific research from ETH Zurich, École Polytechnique Fédérale de Lausanne, University of Zurich, and other Swiss institutions by linking them to market actors such as Nestlé, Roche, Novartis, and ABB.
Innosuisse was established in 2018 as a successor to the Commission for Technology and Innovation (CTI) following reforms under the Swiss Federal Council and the Swiss Parliament to modernize innovation policy instruments. Its creation followed policy reviews involving stakeholders from ETH Board, Swiss National Science Foundation, European Commission programs like Horizon 2020, and industry associations including Swissmem and Swiss Startup Association. The agency built on historical collaborations among ETH Zurich, University of Geneva, University of Lausanne, University of Bern, and cantonal research offices, and adapted practices from international models such as Innovate UK, Bpifrance, Fraunhofer-Gesellschaft, and German Federal Ministry of Education and Research reforms.
Innosuisse operates under the oversight of the State Secretariat for Education, Research and Innovation and is accountable to the Federal Department of Economic Affairs, Education and Research. Its governance includes a board reflecting representatives from industry, academia, and cantonal authorities, drawing expertise from institutions like ETH Board, EPFL, University of Basel, and corporations including UBS and Credit Suisse. Operational divisions coordinate peer review panels composed of international experts from MIT, Stanford University, Max Planck Society, Imperial College London, and ETH Zurich to evaluate project proposals. Financial controls align with standards used by European Investment Bank and auditing practices from Swiss Federal Audit Office.
Innosuisse runs competitive calls for collaborative projects, startup coaching, coaching for SMEs, and support for international R&D partnerships, modeled on instruments from Horizon Europe, EUREKA, and bilateral calls with Research Council of Norway and Swiss Innovation Agency counterparts. Funding mechanisms include grants for collaborative applied research between universities such as University of Fribourg and companies like Geberit, innovation vouchers, business incubator support connected to EPFL Innovation Park and Technopark Zurich, and coaching aligned with accelerators like Y Combinator and Techstars. Programs also connect to certification and labeling schemes used by ISO standards bodies and sectoral clusters such as Life Sciences Switzerland and Swiss ICT.
Project selection relies on peer review, impact metrics, and stage-gate evaluations drawing on evaluation frameworks from OECD, World Intellectual Property Organization, and empirical studies published by Swiss Federal Statistical Office and university research groups at ETH Zurich and University of St. Gallen. Reported outcomes include new patents, spin-offs from institutions like ETH Zurich and EPFL, product launches by firms such as Roche and Sonova, and increased private co-funding from investors including Redalpine, Index Ventures, and Sequoia Capital. Impact assessments reference case studies comparable to those analyzed by European Commission and metrics used in analyses by McKinsey & Company and Boston Consulting Group.
Innosuisse engages in bilateral and multilateral initiatives with agencies such as Innovate UK, Business Finland, Enterprise Ireland, and programs under EUREKA and previous Horizon 2020 consortia. It facilitates cooperation among research institutions including Karolinska Institutet, University of Oxford, University of Cambridge, TU Delft, and corporate partners like Siemens and Philips. The agency participates in mobility and exchange schemes involving Marie Skłodowska-Curie Actions alumni networks and aligns with international standards from ISO and interoperability efforts with European Research Area frameworks.
Critiques of the agency mirror debates in innovation policy involving allocation efficiency, administrative overhead, and selection bias toward established institutions such as ETH Zurich and large firms like Novartis and Roche, as debated in articles by NZZ, Le Temps, and analysis from think tanks like Avenir Suisse and Center for Economic Policy Research. Some observers have raised concerns about access for regional actors including cantonal universities in Canton Ticino and Canton Jura, potential crowding-out of private venture capital firms such as Blue Ocean Ventures, and alignment with digital policy controversies discussed in forums hosted by Swiss Cybersecurity Advisory and civil society organizations like Public Eye. Governance debates have referenced oversight roles of the Swiss Federal Audit Office and policy signals from the Swiss Parliament.